Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00382577 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Itopride vs Placebo in Heartburn
A Phase 3 study, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 48
- Enrollment target
NCT00382577 is a Phase 3 study that has completed, run by Forest Laboratories. The registered enrollment target is 48 participants.
The verdict
NCT00382577, a Phase 3 study, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of itopride in patients with heartburn.
Interventions
- DRUG Placebo
- DRUG Itopride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2006-10 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00382577
The ClinicalTrials.gov registry entry for NCT00382577 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00382577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00382577 about?
NCT00382577 is a clinical study titled "Efficacy and Safety of Itopride vs Placebo in Heartburn". The purpose of this study is to evaluate the effects of itopride in patients with heartburn.
What is the current status of trial NCT00382577?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 48 participants. The study started on 2006-10. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00382577?
The interventions under investigation include: Placebo (DRUG), Itopride (DRUG).
Who is sponsoring clinical trial NCT00382577?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.